Quenching of Hoechst 33258 fluorescence in erythroid precursors.
Quenching of the fluorescence of DNA-bound Hoechst 33258 in erythroid precursors was studied by flow cytometry and cytochemistry. This quenching artifact may affect the measurement of ploidy in specific cases. The bone marrow cells of two patients with hemolytic disease and active erythropoiesis contained subpopulations of cells with an apparent hypodiploid DNA content as measured by flow cytometry of paraformaldehyde-fixed cells stained with Hoechst 33258. No aneuploidy was detected in either of the two cases when cells were stained with mithramycin or 7-aminoactinomycin D. Cells exhibiting reduced Hoechst 33258 fluorescence expressed glycophorin A and low amounts of CD36, and were therefore erythroid precursors. In one case studied, the number of cells with reduced Hoechst 33258 fluorescence and glycophorin A expressed agreed well with the number of cells containing nuclear hemoglobin. In the other case, hemoglobin was present in a significant proportion of nucleated cells. Calculated values for the efficiency of resonance energy transfer from Hoechst 33258 to hemoglobin were in accordance with the observed levels of quenching (approximately 10%). However, the results could also be explained by hemoglobin reabsorption of Hoechst 33258 fluorescence. Nuclei stained with Hoechst 33258 showed uniform fluorescence, probably due to extraction of hemoglobin during the isolation procedure.
Stokke
T
T
Department of Biophysics, Norwegian Radiumhospital, Oslo.
Holte
H
H
Davies
C D
CD
Steen
H B
HB
Lie
S O
SO
D001562:Benzimidazoles / Q000097:blood*; D006690:Bisbenzimidazole / Q000097:blood*; D001854:Bone Marrow Cells; D015672:Erythroid Precursor Cells / Q000378:metabolism*; D005434:Flow Cytometry; D005453:Fluorescence; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans
D001562:Benzimidazoles; D006454:Hemoglobins; D006690:Bisbenzimidazole